1.
Glaser DA, Hebert AA, Nast A, Werschler WP, Shideler S, Green L, Mamelok RD, Drew J, Quiring J, Pariser DM. Open-Label Study (ARIDO) Evaluating Long-Term Safety of Topical Glycopyrronium Tosylate (GT) in Patients with Primary Axillary Hyperhydrosis. J of Skin [Internet]. 2018Feb.23 [cited 2023Jan.26];2(S1):S40. Available from: https://www.jofskin.org/index.php/skin/article/view/268